Skip NavigationSkip to Content

Population survey of CCR5 Delta 32, CCR5 m303, CCR2b 64I, and SDF1 3 ' A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups

  1. Author:
    Wang, F. S.
    Hong, W. G.
    Cao, Y. Z.
    Liu, M. X.
    Jin, L.
    Hu, L. P.
    Wang, Z.
    Feng, T. J.
    Hou, J.
    Zhang, B.
    Shi, M.
    Xu, D. P.
    Lei, Z. Y.
    Wang, B.
    Liu, Z. D.
    Ye, J. J.
    Peng, L.
    Qiu, Y.
    Winkler, C.
  2. Author Address

    Beijing Inst Infect Dis, Div Biol Engn, 26 Feng Tai Rd, Beijing 100039, Peoples R China Beijing Hosp Infect Dis, Beijing Inst Infect Dis, Div Biol Engn, Beijing, Peoples R China Natl Ctr AIDS Prevent & Control, Beijing, Peoples R China Inst Med Informat, Div Med Stat, Beijing, Peoples R China Hlth & Antiepidem Ctr Henan Province, Zhengzhou, Peoples R China Shenzhen Hlth & Antiepidem Stn, Shenzhen, Guangdong Prov, Peoples R China Hlth & Antiepidem Ctr Xin Jiang Autonomous Reg, Mulomuqi, Peoples R China Sci & Technol Inst Family Planning, Kunming, Yunnan Province, Peoples R China NCI, Basic Res Program, SAIC Frederick Inc, Frederick, MD 21701 USA Wang FS Beijing Inst Infect Dis, Div Biol Engn, 26 Feng Tai Rd, Beijing 100039, Peoples R China
    1. Year: 2003
  1. Journal: Jaids-Journal of Acquired Immune Deficiency Syndromes
    1. 32
    2. 2
    3. Pages: 124-130
  2. Type of Article: Article
  1. Abstract:

    The aim of this study is to determine in indigenous Chinese ethnic groups the frequencies of the chemokine (SDFI 3'A) and chemokine receptors (CCR5 Delta32, CCR5 m303, and CCR2b 641) HIV-1/AIDS restriction alleles. The study includes two cohorts; the first comprised 3165 indigenous healthy subjects representing eight ethnic groups: Han (n = 1406), Uygur (n = 316), Mongolia (n = 134), Hui (n = 386), Tibetan (n = 330), Zhuang (n = 378), Dai (n = 101), and Jingbo (n = 114). The second cohort consisted of 330 HIV-1-infected (86 subjects infected by sexual transmission and 198 subjects infected by HIV-1-contaminated blood or by sharing injection equipment; the remaining 46 subjects said nothing about HIV-1 transmission) and 474 HIV-1-uninfected Han Chinese belonging to one of two HIV-1 high-risk groups: intravenous drug users (n = 215) and individuals with sexually transmitted diseases (n = 259). Genotypes for the four genes were obtained using PCR (CCR5 Delta32) or PCR-restriction fragment length polymorphism. Randomly selected amplified PCR products were further confirmed by direct DNA sequencing. The variant allele frequencies were determined to be 0% to 3.48% for CCR5 Delta32, 0% for CCR5 m303, 16.23% to 28.79% for CCR2b 641, and 17.70% to 27.76% for SDFI 3'A in Chinese healthy individuals from eight ethnic groups. These findings show that allele frequencies differ among the eight Chinese ethnic groups for CCR5 Delta32, CCR2b 641, and SDFI 3'A and that the CCR5 m303 and CCR5 Delta32 mutant alleles were absent or infrequent in Chinese, which may be helpful for studies of specific anti-HIV-1 vaccine trials and coreceptor inhibitor drug targets in Chinese populations. Furthermore, we observed no significant differences in allele or genotypic frequencies between HIV-1-infected and HIV-1- uninfected groups from the Han ethnic group. Our finding is the first reporting that there is likely no effect of the examined polymorphisms in our study on HIV-1 transmission in the Chinese Han population, However, the genetic effects of these and other AIDS-modifying polymorphisms on the pathogenesis and clinical outcome of HIV-1/AIDS diseases is under investigation in Chinese populations.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel